FWD Hong Kong has introduced the One&All Medical Insurance Plan, designed with tiered benefits that reflect hospital categories and geographical scope.
The plan aims to ease financial exposure for residents who rely heavily on public healthcare but face costs from drugs and services not fully subsidised.
Government data indicates that more than half of Hong Kong residents do not own private health cover.
At the same time, patients in the public system may encounter substantial out-of-pocket expenses for self-financed drugs, procedures, or delays in accessing diagnostic imaging.
FWD said the new plan responds to these gaps by providing coverage options that align with different affordability levels.
The product is structured in three tiers.
Level Access targets individuals without existing medical cover, offering protection for self-financed items in public hospitals and for private imaging referrals.
It also provides cash benefits for hospital stays or day surgery globally.
Coverage is capped at HK$500,000 per disability annually, with enrolment requiring only three health questions.
Level Beyond expands the benefits to treatment in both public and private hospitals in Mainland China and Macau, with an annual maximum of HK$850,000 per disability.
Level Connect offers the broadest protection, covering hospitals across Asia, with an annual maximum of HK$1 million per disability.
This level also includes an option to add parents without medical underwriting, giving them similar benefits to Level Access after a waiting period.
Kelvin Yu (pictured left), chief product officer for FWD Hong Kong and Macau, said the plan addresses financial pressure from medical bills.
“The newly launched ‘One&All Medical Insurance Plan’ incorporates ESG principles to offer more accessible and affordable protection for our customers and the community,” he said.
He noted that while only a small percentage of patients incur more than HK$10,000 in public hospital charges, cancer patients in particular may face drug costs of up to HK$400,000 annually.
Yu said the plan’s tiered design and parental coverage option were developed to reduce the financial impact on households.
“One&All offers coverage segmented by hospital type, addressing the pain points of those who lack adequate medical protection, such as the inability to afford high-cost self-financed items in public hospitals, or the risk of missing the crucial treatment window due to long waiting times for imaging tests in the public system. Optional benefit can also be applied for parents without any health underwriting,” he said.
Alongside the launch, FWD is working with the Hong Kong Pharmaceutical Care Foundation to provide customers with drug consultation and medication management services.
The foundation, a non-profit organisation, will offer remote consultation, pharmacist-led one-on-one guidance, and access to discounts at partner dispensaries.
According to foundation director S.C. Chiang (pictured right), the initiative is intended to improve safe use of medicine at a time when treatment regimens are becoming increasingly complex.
“With the rapid advancement of medical technology today, the range of available medication is constantly increasing. When faced with complex prescriptions, many people struggle to obtain adequate consultation and guidance, which can lead to uncertainty and may even impact treatment outcomes if medications are not used correctly,” she said.
The launch also aligns with broader changes in public attitudes toward health.
The Manulife Asia Care Survey 2025 found that many Hong Kong residents now define good health less by longevity and more by independence and the ability to engage in meaningful activities.
Of the 1,000 respondents surveyed, 77% said autonomy was central to their definition of health, while priorities included maintaining physical and mental well-being (47%), financial security (41%), and preserving lifestyle choices (33%).
